2013 annual financial data
UroGen Pharma 2013 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -3,389,000 USD and net income was -3,306,000 USD.
Operating cash flow was -2,557,000 USD.
Get free UroGen Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -3,389,000 USD
- Net income
- -3,306,000 USD
- Operating cash flow
- -2,557,000 USD